Intelligent Medicine Acquisition Corp.
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand20.70M Perf Week-1.76%
Market Cap259.81M Forward P/E- EPS next Y- Insider Trans- Shs Float20.70M Perf Month-2.51%
Income- PEG- EPS next Q- Inst Own2.08% Short Float / Ratio0.00% / 0.04 Perf Quarter-0.20%
Sales- P/S- EPS this Y- Inst Trans- Short Interest0.00M Perf Half Y0.40%
Book/sh-0.47 P/B- EPS next Y- ROA- Target Price- Perf Year-1.08%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.90 - 10.58 Perf YTD-1.66%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-4.71% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low1.82% ATR0.09
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)43.31 Volatility0.00% 0.40%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.01 Prev Close10.27
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.25K Price10.08
Recom- SMA20-1.21% SMA50-1.59% SMA200-0.43% Volume50 Change-1.85%
Feb-08-23 09:47AM
Feb-03-23 05:00PM
Apr-05-22 05:16PM
Dec-23-21 04:05PM
Nov-09-21 09:18PM
06:23PM Loading…
Nov-04-21 06:23PM
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.